trans-4-Cyclohexylcyclohexylamine | 6623-10-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: trans-4-Cyclohexylcyclohexylamine
• 英文别名: 4-cis-cyclohexylcyclohexylamine；bicyclohexyl-4-ylamine；4-Amino-bicyclohexyl；4-cyclohexylcyclohexylamine；[Bicyclohexyl]-4-amine；4-cyclohexylcyclohexan-1-amine
• CAS: 6623-10-5
• 化学式: C₁₂H₂₃N
• 分子量: 181.321
• InChiKey: HUCGKSXUGYWDMJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  2-甲基环己酮 、 苯胺 、 盐酸 、 sodium hydroxide 在 ice 作用下， 以 乙酸乙酯 、 乙醇 为溶剂， 反应 168.5h， 生成 trans-4-Cyclohexylcyclohexylamine
  参考文献：
  名称：

  Glucagon antagonists/inverse agonists

  摘要：

  一类新型化合物，能够拮抗胰高血糖素激素对胰高血糖素受体的作用。由于它们对胰高血糖素受体的拮抗作用，这些化合物可能适用于治疗和/或预防任何需要胰高血糖素拮抗作用有益的疾病和疾病，例如高血糖症、1型糖尿病、2型糖尿病、脂质代谢紊乱，如血脂异常和肥胖症。

  公开号：

  US06953812B2

文献信息

• FLUORINATED SULFONATE ESTERS OF ARYL KETONES FOR NON-IONIC PHOTO-ACID GENERATORS
  申请人：International Business Machines Corporation

  公开号：US20180046077A1

  公开（公告）日：2018-02-15

  Non-ionic photo-acid generating (PAG) compounds were prepared that contain an aryl ketone group having a perfluorinated substituent alpha to the ketone carbonyl. The non-polymeric PAGs release a sulfonic acid when exposed to high energy radiation such as deep UV or extreme UV light. The photo-generated sulfonic acid has a low diffusion rate in an exposed resist layer subjected to a post-exposure bake (PEB) at 100° C. to 150° C., resulting in formation of good line patterns after development. At higher temperatures, the PAGs can also undergo a thermal reaction to form a sulfonic acid. The perfluorinated substituent provides improved thermal stability and hydrolytic/nucleophilic stability.

  非离子型光生酸(PAG)化合物被制备出来，它们含有一个含有全氟取代基的芳酮基团，该取代基位于酮羰基的α位置。这些非聚合PAGs在暴露于高能辐射，如深紫外或极紫外光时，会释放出磺酸。在100°C至150°C的后曝光烘烤(PEB)下，光生成的磺酸在暴露的抵抗层中具有较低的扩散速率，从而在开发后形成良好的线条图案。在较高温度下，PAGs也可以通过热反应形成磺酸。全氟取代基提供了改善的热稳定性和水解/亲核稳定性。
• Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same
  申请人：Darwish Ihab S.

  公开号：US20090163511A1

  公开（公告）日：2009-06-25

  Disclosed are carboxamide, sulfonamide and amine compounds, as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure in which R 1 , R 2 , R 4 , D, E, J, T, p, q and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.

  揭示了羧酰胺、磺胺和胺类化合物，以及药物组合物和使用方法。其中一种实施例是具有以下结构的化合物 其中R 1 ，R 2 ，R 4 ，D，E，J，T，p，q和x如本文所述。在某些实施例中，本文所披露的化合物可以激活AMPK途径，并可用于治疗与代谢有关的疾病和症状。
• NON-IONIC LOW DIFFUSING PHOTO-ACID GENERATORS
  申请人：International Business Machines Corporation

  公开号：US20180044284A1

  公开（公告）日：2018-02-15

  Non-ionic photo-acid generating (PAG) compounds were prepared that contain an aryl ketone group. The disclosed non-polymeric PAGs release a strong sulfonic acid when exposed to high energy radiation such as deep UV or extreme UV light. The photo-generated sulfonic acid has a low diffusion rate in an exposed resist layer subjected to a post-exposure bake (PEB) at 100° C. to 150° C., resulting in formation of good line patterns after development. At higher temperatures, the PAGs undergo a thermal reaction to form a sulfonic acid.

  制备了含芳基酮基团的非离子光酸发生（PAG）化合物。揭示的非聚合物PAG在暴露于高能辐射（如深紫外或极紫外光）时释放出强磺酸。光生磺酸在经过后曝光烘烤（PEB）处理（在100°C至150°C下）的受暴露光阻层中具有低扩散速率，从而在显影后形成良好的线条图案。在较高温度下，PAG会发生热反应形成磺酸。
• [EN] GLUCAGON ANTAGONISTS/INVERSE AGONISTS<br/>[FR] ANTAGONISTES/AGONISTES INVERSES DU GLUCAGON
  申请人：NOVO NORDISK AS

  公开号：WO2002000612A1

  公开（公告）日：2002-01-03

  A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any diseases and disorders, wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism and obesity.

  一种新型化合物，其作用是对抗胰高血糖素激素对胰高血糖素受体的作用。由于这些化合物对胰高血糖素受体的拮抗作用，因此这些化合物可能适用于治疗和/或预防任何需要胰高血糖素拮抗作用的疾病和障碍，例如高血糖症、1型糖尿病、2型糖尿病、脂质代谢障碍和肥胖症。
• Compounds for sustained release of orally delivered drugs
  申请人：Gallop A. Mark

  公开号：US20050054559A1

  公开（公告）日：2005-03-10

  Disclosed are methods for providing sustained systemic blood concentrations of orally delivered drugs. Still further, disclosed are compounds and pharmaceutical compositions that are used in such methods.

  本发明涉及提供口服药物的持续系统血浓度的方法。此外，本发明还涉及用于这种方法的化合物和制药组合物。